Richard Fair

Richard Fair

Amministratore Delegato presso ENLIVEN THERAPEUTICS, INC.
57 anni
Health Technology
Consumer Services
Distribution Services

Profilo

Mr. Richard A. Fair is a Chief Executive Officer & Director at Enliven Therapeutics, Inc. /US/, a President, Chief Executive Officer & Director at Enliven Therapeutics, Inc. and a President & Director at Bellicum Pharmaceuticals, Inc. He is on the Board of Directors at Enliven Therapeutics, Inc. /US/, Enliven Therapeutics, Inc. and Bellicum Pharmaceuticals, Inc. Mr. Fair was previously employed as an Independent Director by Clovis Oncology, Inc., a SVP & Head-Therapeutic Oncology Global Product by Genentech, Inc., and a Franchise Head-Hematology by Roche Pharma (Schweiz) AG.
He received his undergraduate degree from the University of Michigan and an MBA from Columbia Business School.

Posizioni attive di Richard Fair

SocietàPosizioneInizio
BELLICUM PHARMACEUTICALS, INC. Presidente 31/01/2017
ENLIVEN THERAPEUTICS, INC. Amministratore Delegato 11/12/2025
Amministratore Delegato 11/12/2025

Precedenti posizioni note di Richard Fair

SocietàPosizioneFine
CLOVIS ONCOLOGY, INC. Direttore/Membro del Consiglio 10/07/2023
Corporate Officer/Principal 01/01/2017
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Richard Fair

Formazione di Richard Fair

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

96

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private8

Health Technology

Health Technology

Consumer Services

Health Technology

Distribution Services

Consumer Services

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Richard Fair
-40%: Proroga eccezionale
g
:
:
ENTRA ORA